Found: 4
Select item for more details and to access through your institution.
Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 12, p. 3511, doi. 10.1007/s00432-022-04248-y
- By:
- Publication type:
- Article
Corrigendum to "Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models".
- Published in:
- 2019
- By:
- Publication type:
- journal article
Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Bortezomib improves adoptive carbonic anhydrase IX-specific chimeric antigen receptor-modified NK92 cell therapy in mouse models of human renal cell carcinoma.
- Published in:
- Oncology Reports, 2018, v. 40, n. 6, p. 3714, doi. 10.3892/or.2018.6731
- By:
- Publication type:
- Article